Merck obtains US approval for its pneumonia vaccine to compete with Pfizer
Health

Merck obtains US approval for its pneumonia vaccine to compete with Pfizer

Photo of MR MBR MR MBR Follow on X Send an email 2 weeks agoLast Updated: June 18, 2024
1 Less than a minute

Merck & Co. has gained U.S. approval for a pneumococcal vaccine that threatens to unseat one among Pfizer’s largest subsidiaries.

Merck’s vaccine, known as Capvaxive, has been permitted to forestall bacterial infections inflicting pneumonia and meningitis in adults over 18, Merck mentioned Monday.

What’s Your Reaction?
0
0
0
0
0
0
0
Tags
Photo of MR MBR MR MBR Follow on X Send an email 2 weeks agoLast Updated: June 18, 2024
1 Less than a minute
Photo of MR MBR

MR MBR

Hi I Am Muddala Bulli Raju And I'm A Web Designer And Content Writer On MRMBR.COM